Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.45), $0.19 better than the analyst estimate of ($1.64). Revenue for the quarter came in at $8.19 million versus the consensus estimate of $8.69 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.